LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83 rd American Academy of ...

As Taiwan marked the 78th anniversary of a 1947 massacre by nationalist troops, two photos were shared in posts that falsely ...

Bogotá enfrentó varios días de lluvias que dejaron calles inundadas a mediados de marzo de 2025. Durante el fenómeno, un ...

Mark Gerardts será el nuevo director ejecutivo de Maxion Wheels, en sustitución de Klinkers. Gerardts, actual presidente de la Unidad de Negocio para Europa, Oriente Medio y África (EMEA), se ...

Desde que o presidente norte-americano, Donald Trump, nomeou Robert F. Kennedy Jr. — que já espalhou alegações falsas sobre vacinas — para a área da saúde em seu governo, peças de desinformação sobre ...

DUBAI GAMES 2025 has reached its grand finale, celebrating the pinnacle of international team sports and uniting athletes in a showcase of endurance, innovation, and collaboration. Today, the ...

Gurobi Optimization, LLC, le leader des technologies d'intelligence décisionnelle, a le plaisir d'annoncer le lancement de Gurobi AI Modeling, un nouvel ensemble d’outils qui enseigne aux ...

McKay Brothers International launched the lowest latency connectivity between key crypto trading hubs in Tokyo with those in London and Dublin. The new service achieves sub-132ms latency (round ...

A growing number of enterprises in Asia Pacific are seeking Oracle ecosystem services to help them carry out digital transformations to remain competitive in rapidly changing markets, according to ...

x-hoppers, die KI-gestützte Kommunikationsplattform für den Einzelhandel, hat nach der mit Spannung erwarteten Markteinführung in Deutschland auf der EuroCIS 2025 den erfolgreichen Soft Launch ...

Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode™ single cell ...

MatriceLab Innove announced that the first large-scale randomized controlled trial investigating endometrial immune profiling showed that personalized treatment based on immune testing can ...